Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
B2 Equity Holdings is the investment arm of the Biggers family, providing $2 million to $10 million in angel, early, and late stage capital. The company invests across various sectors including technology (notably real estate tech), beauty/personal care, and other industries. There is no evidence that it operates in life sciences, biotech, pharma, or healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on B2 Equity Holdings.